Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone Acetate vs Betamethasone Valerate in Dermatosis
NCT01011621Phase 3Unknown
- Sponsor
- Mantecorp Farmasa
- Start
- Feb 2010
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, open-label trial of prednisolone in atopic dermatitis (AD), contact dermatitis, seborrheic dermatitis (SD) and 1 more (2 arms), sponsored by Mantecorp Farmasa. Primary endpoint: Efficacy and Safety Evaluation at 14 days. Status: unknown.
02
Drugs
prednisolone
03
Conditions
atopic dermatitis (AD)contact dermatitisseborrheic dermatitis (SD)psoriasis
Beyond the preview
Go deeper on NCT01011621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011621.